| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,340,000,000 |
| Market
Cap: |
106.85(B) |
| Last
Volume: |
23,255,346 |
Avg
Vol: |
0 |
| 52
Week Range: |
$69.43 - $91.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 125 |
| Guru Rank Value : 7.5 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Medtronic is a medical technology, services and solutions company. Co.'s four operating and reportable segments are as follows: Cardiovascular Portfolio, which is made up of the cardiac rhythm and heart failure, structural heart and aortic, and coronary and peripheral vascular divisions; Medical Surgical Portfolio, which is made up of the surgical innovations and respiratory, gastrointestinal, and renal divisions; Neuroscience Portfolio is made up of the cranial and spinal technologies, specialty therapies, and neuromodulation divisions; and Diabetes Operating Unit, which develops, manufactures, and markets products and services for the management of Type 1 and Type 2 diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
31,549 |
36,546 |
56,412 |
75,447 |
| Total Sell Value |
$2,684,057 |
$3,094,660 |
$4,783,517 |
$6,318,268 |
| Total People Sold |
2 |
3 |
5 |
5 |
| Total Sell Transactions |
2 |
3 |
8 |
10 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ten Hoedt Rob |
EVP and Pres. Global Regions |
• • – |
2022-10-14 |
4 |
OE |
$41.60 |
$100,006 |
D/D |
2,404 |
45,887 |
|
- |
|
| Fong Ivan K |
EVP GENERAL COUNSEL & SECR |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
6,941 |
37,722 |
|
- |
|
| Salmon Sean |
EVP & President Cardiovascular |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,595 |
36,214 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,744 |
30,962 |
|
- |
|
| Surface Carol A |
EVP, Chief HR Officer |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,157 |
26,193 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,306 |
43,483 |
|
- |
|
| Martha Geoffrey |
Chairman and CEO |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,471 |
102,497 |
|
- |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
8,595 |
36,351 |
|
- |
|
| Wall Brett A. |
EVP & Pres Neuroscience |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,521 |
25,646 |
|
- |
|
| Smith Gregory L |
EVP Global Ops & Supply Chain |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
5,587 |
34,783 |
|
- |
|
| Kirk Jennifer M |
Chief Accounting Officer |
• • – |
2022-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,364 |
10,630 |
|
- |
|
| White Robert John |
EVP & Pres. Medical Surgical |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,397) |
27,756 |
|
- |
|
| Wall Brett A. |
EVP & Pres Neuroscience |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,493) |
18,125 |
|
- |
|
| Parkhill Karen L |
EVP & Chief Financial Officer |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,151) |
20,218 |
|
- |
|
| Salmon Sean |
EVP & President Cardiovascular |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,808) |
27,619 |
|
- |
|
| Martha Geoffrey |
Chairman and CEO |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,410) |
74,026 |
|
- |
|
| Surface Carol A |
EVP, Chief HR Officer |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,920) |
21,036 |
|
- |
|
| Ten Hoedt Rob |
EVP & President EMEA |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,641) |
36,177 |
|
- |
|
| Liddicoat John R |
EVP & President of Americas |
• • – |
2022-07-29 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,543) |
37,374 |
|
- |
|
| Smith Gregory L |
EVP Global Ops & Supply ChainO |
• – – |
2022-06-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,905 |
|
-6% |
|
| Hogan Randall J |
Director |
• • – |
2022-05-03 |
4 |
D |
$103.11 |
$27,015 |
D/D |
(262) |
4,147 |
|
- |
|
| Nabel Elizabeth G |
Director |
• • – |
2022-05-03 |
4 |
D |
$103.11 |
$27,015 |
D/D |
(262) |
11,818 |
|
- |
|
| Anderson Richard H |
Director |
• • – |
2022-05-03 |
4 |
D |
$103.11 |
$27,015 |
D/D |
(262) |
110,182 |
|
- |
|
| Powell Kendall J |
Director |
• • – |
2022-05-03 |
4 |
D |
$103.11 |
$27,015 |
D/D |
(262) |
37,417 |
|
- |
|
| Craig Arnold |
Director |
• • – |
2022-05-03 |
4 |
D |
$103.11 |
$27,015 |
D/D |
(262) |
34,419 |
|
- |
|
681 Records found
|
|
Page 4 of 28 |
|
|
0.49 (0.62%) 
